Sign inJoin waitlistJoin the waitlist

Thomas Schnitzer

Professor, Physical Medicine and Rehabilitation · McGaw Medical Center of Northwestern University

Credentials: · · ·

History

McGaw Medical Center of Northwestern University
Present

Rheumatology
1973–1975
Johns Hopkins University School of Medicine
1971–1973
Harvard Medical School
1967–1971

Research

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group
New England Journal of Medicine · 2000 · 2,932 citations
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
Systematic review or meta-analysis · The Lancet · 2013 · 1,268 citations
Clopidogrel with or without omeprazole in coronary artery disease
New England Journal of Medicine · 2010 · 932 citations

Marc Hochberg
15 papers
Joana Monteiro
13 papers · 13 as a resident
David Hunter
10 papers
Loren Laine
10 papers
DY
David Yocum
7 papers
FW
Frederick Wolfe
7 papers
Joel Block
7 papers
Larry Moreland
7 papers
Nancy Lane
7 papers
Souraya Torbey
7 papers · 4 as a resident
AK
Alan Kivitz
6 papers
TA
Taha Abdullah
6 papers

Grants

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee OA
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $2.7M · Northwestern University
2023–2028
Denosumab and Sequential Zoledronic Acid to Prevent Bone Loss and Maintain Bone Mass After Spinal Cord Injury
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R34
Contact PI · $394.1K · Northwestern University
2024–2026
Reovirus Arthritis: Pathogenetic Mechanisms
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $102.6K · Rush University Medical Center
1985–1988
Reovirus Arthritis: Pathogenetic Mechanisms
NIADDK · R01
Contact PI · $102.6K · Rush University Medical Center
1985–1987

Clinical trials

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
Principal investigator · Recruiting · Phase 4
Northwestern University
2024–2028
Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain
Principal investigator · Completed
Paradigm Biopharmaceuticals Ltd.
2023–2024
Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis
Principal investigator · Active not recruiting · Phase 4
Northwestern University
2022–2027
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
Principal investigator · Active not recruiting · Phase 2, Phase 3
Paradigm Biopharmaceuticals USA (INC)
2021–2025